» Articles » PMID: 23326393

Hoxa9 Transduction Induces Hematopoietic Stem and Progenitor Cell Activity Through Direct Down-regulation of Geminin Protein

Overview
Journal PLoS One
Date 2013 Jan 18
PMID 23326393
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Hoxb4, a 3'-located Hox gene, enhances hematopoietic stem cell (HSC) activity, while a subset of 5'-located Hox genes is involved in hematopoiesis and leukemogenesis, and some of them are common translocation partners for Nucleoporin 98 (Nup98) in patients with leukemia. Although these Hox gene derivatives are believed to act as transcription regulators, the molecular involvement of the Hox gene derivatives in hematopoiesis and leukemogenesis remains largely elusive. Since we previously showed that Hoxb4 forms a complex with a Roc1-Ddb1-Cul4a ubiquitin ligase core component and functions as an E3 ubiquitin ligase activator for Geminin, we here examined the E3 ubiquitin ligase activities of the 5'-located Hox genes, Hoxa9 and Hoxc13, and Nup98-Hoxa9. Hoxa9 formed a similar complex with the Roc1-Ddb1-Cul4a component to induce ubiquitination of Geminin, but the others did not. Retroviral transduction-mediated overexpression or siRNA-mediated knock-down of Hoxa9 respectively down-regulated or up-regulated Geminin in hematopoietic cells. And Hoxa9 transduction-induced repopulating and clonogenic activities were suppressed by Geminin supertransduction. These findings suggest that Hoxa9 and Hoxb4 differ from Hoxc13 and Nup98-Hoxa9 in their molecular role in hematopoiesis, and that Hoxa9 induces the activity of HSCs and hematopoietic progenitors at least in part through direct down-regulation of Geminin.

Citing Articles

Posttranscriptional activity of the eukaryotic translation initiation factor eIF4E contributes to HoxA9-driven leukemogenesis.

Zhou F, Culjkovic-Kraljacic B, Bach C, Feng L, Mishima Y, Borden K bioRxiv. 2025; .

PMID: 39990322 PMC: 11844429. DOI: 10.1101/2025.02.10.637540.


Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential.

Tang L, Peng L, Tan C, Liu H, Chen P, Wang H Cancer Cell Int. 2022; 22(1):349.

PMID: 36376832 PMC: 9664671. DOI: 10.1186/s12935-022-02767-9.


Overexpression of HOXA9 upregulates NF-κB signaling to promote human hematopoiesis and alter the hematopoietic differentiation potentials.

Zeng J, Yi D, Sun W, Liu Y, Chang J, Zhu L Cell Regen. 2021; 10(1):9.

PMID: 33426581 PMC: 7797385. DOI: 10.1186/s13619-020-00066-0.


Regulation of geminin by neuropeptide Y in vascular smooth muscle cell proliferation : A current review.

Liang S, Zhou Y, Shu M, Lin S Herz. 2018; 44(8):712-716.

PMID: 30151710 DOI: 10.1007/s00059-018-4721-3.


Role of Geminin in cell fate determination of hematopoietic stem cells (HSCs).

Yasunaga S, Ohno Y, Shirasu N, Zhang B, Suzuki-Takedachi K, Ohtsubo M Int J Hematol. 2016; 104(3):324-9.

PMID: 27422432 DOI: 10.1007/s12185-016-2060-9.


References
1.
Lawrence H, Helgason C, Sauvageau G, Fong S, Izon D, Humphries R . Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood. 1997; 89(6):1922-30. View

2.
Takihara Y, Hara J . Polycomb-group genes and hematopoiesis. Int J Hematol. 2000; 72(2):165-72. View

3.
Moore M . Converging pathways in leukemogenesis and stem cell self-renewal. Exp Hematol. 2005; 33(7):719-37. DOI: 10.1016/j.exphem.2005.04.011. View

4.
Lebert-Ghali C, Fournier M, Dickson G, Thompson A, Sauvageau G, Bijl J . HoxA cluster is haploinsufficient for activity of hematopoietic stem and progenitor cells. Exp Hematol. 2010; 38(11):1074-1086.e1-5. DOI: 10.1016/j.exphem.2010.07.006. View

5.
Wilson A, Laurenti E, Oser G, van der Wath R, Blanco-Bose W, Jaworski M . Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008; 135(6):1118-29. DOI: 10.1016/j.cell.2008.10.048. View